These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24471447)

  • 1. The expanding role of therapeutic antibodies.
    Salemi S; Markovic M; Martini G; D'Amelio R
    Int Rev Immunol; 2015 May; 34(3):202-64. PubMed ID: 24471447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and use of therapeutic antibodies primarily of human origin.
    Stiehm ER; Keller MA; Vyas GN
    Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-directed therapy: past, present, and future.
    Gelfand EW
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S111-6. PubMed ID: 11586277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody production: polyclonal-derived biotherapeutics.
    Newcombe C; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):2-7. PubMed ID: 16893686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targets of monoclonal antibodies for immunological diseases.
    Yoo SM; Chung SH
    Arch Pharm Res; 2019 Apr; 42(4):293-304. PubMed ID: 30426387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant polyclonal antibodies: the next generation of antibody therapeutics?
    Haurum JS
    Drug Discov Today; 2006 Jul; 11(13-14):655-60. PubMed ID: 16793535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies.
    Berger M
    Curr Allergy Asthma Rep; 2002 Sep; 2(5):368-78. PubMed ID: 12165202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class-specific effector functions of therapeutic antibodies.
    Pascal V; Laffleur B; Cogné M
    Methods Mol Biol; 2012; 901():295-317. PubMed ID: 22723109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulins--basic considerations.
    Mix E; Goertsches R; Zett UK
    J Neurol; 2006 Sep; 253 Suppl 5():V9-17. PubMed ID: 16998762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic antibodies in multiple sclerosis.
    Goebels N; Becher B
    Neurodegener Dis; 2008; 5(1):5-7. PubMed ID: 18075268
    [No Abstract]   [Full Text] [Related]  

  • 13. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal and monoclonal antibodies in clinic.
    Wootla B; Denic A; Rodriguez M
    Methods Mol Biol; 2014; 1060():79-110. PubMed ID: 24037837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the validity of animal models for research into therapies for immune-based disorders.
    't Hart BA; Amor S; Jonker M
    Drug Discov Today; 2004 Jun; 9(12):517-24. PubMed ID: 15183159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Therapies of Immunologic Diseases.
    Chipps BE; Peters SP
    Immunol Allergy Clin North Am; 2017 May; 37(2):xvii-xviii. PubMed ID: 28366489
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy with agonistic anti-CD137: two sides of a coin.
    Sun Y; Chen JH; Fu Y
    Cell Mol Immunol; 2004 Feb; 1(1):31-6. PubMed ID: 16212918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies as medication].
    Kurki P; Jalanko H
    Duodecim; 1995; 111(8):788-96. PubMed ID: 8681839
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in the pursuit of immune tolerance.
    Nepom GT; St Clair EW; Turka LA
    Immunol Rev; 2011 May; 241(1):49-62. PubMed ID: 21488889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From Bogomoletz anti-reticular cytotoxic serum to monoclonal antibodies].
    Aleksieieva IM; Ianchiĭ PI
    Fiziol Zh (1994); 2001; 47(2):3-15. PubMed ID: 11392111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.